Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

18 Jul 2019 Evaluate

Cadila Healthcare has informed that it has enclosed press release titled 'Zydus announces completion of enrollment in three Phase III trials of Saroglitazar Magnesium in NASH'.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..